Richard Lerner

Jul 11, 2007

Premium

Sequenom this week announced the appointment of Richard Lerner to its board of directors. Lerner is president of the Scripps Research Institute. Additionally, he servers on the boards of Kraft Foods and Opko Health, formerly eXegenics.

Filed under

Diagnostics

Breaking News

Lander, Collins Offer Vision for Advanced Research Projects Agency for Health
LetsGetChecked Partners With California Department of Public Health for COVID-19 Sequencing
BTIG Initiates Coverage of Berkeley Lights With Buy Rating
Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test
Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products
Leidos Wins CDC Bioinformatics Contract Worth up to $13M

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.